Avacta Group (LON:AVCT) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Avacta Group Plc (LON:AVCTGet Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 63.65 and traded as high as GBX 71. Avacta Group shares last traded at GBX 69.45, with a volume of 865,759 shares.

Avacta Group Trading Up 0.7%

The business’s fifty day moving average price is GBX 59.20 and its 200 day moving average price is GBX 63.65. The company has a quick ratio of 4.96, a current ratio of 0.79 and a debt-to-equity ratio of 14,168.75. The firm has a market capitalization of £303.94 million, a PE ratio of -3.96 and a beta of 1.12.

About Avacta Group

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Read More

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.